glp-1 discovery Machine-Learning-Guided Peptide Drug Discovery: Development of Receptor Agonists with Improved Drug Properties History of GLP-1: From Discovery

Medicines & Healthcare Products Regulatory Agency

Patients with iron overload need close monitoring

To decipher the role of the circadian clock in renal metabolism, we studied diurnal changes in renal metabolic pathways using integrated transcriptomic, proteomic, and metabolomic analysis performed on control mice and mice with an inducible deletion of the circadian clock regulator Bmal1 in the renal tubule (cKOt)

Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: a randomized controlled trial

Orforglipron, developed by Eli Lilly, is an investigational daily pill that mimics the effects of injectable GLP-1 receptor agonists, a class of drugs known to help with weight loss and blood sugar control

Who Should and Should Not Use GLP-1: Safety Considerations GLP-1 is appropriate for adults with type 2 diabetes or obesity meeting clinical criteria and without contraindications